Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Advanced Chronic Kidney Disease

INTRODUCTION: Warfarin remains the preferred oral anticoagulant for the treatment of venous thromboembolism (VTE) in patients with advanced chronic kidney disease (CKD). Although the direct oral anticoagulants (DOACs) have become preferred for treatment of VTE in the general population, patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahuja, Tania, Sessa, Kelly, Merchan, Cristian, Papadopoulos, John, Green, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895609/
https://www.ncbi.nlm.nih.gov/pubmed/33628255
http://dx.doi.org/10.1155/2021/8870015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895609/
https://www.ncbi.nlm.nih.gov/pubmed/33628255
http://dx.doi.org/10.1155/2021/8870015

Ejemplares similares